Cimeio Therapeutics
Cell and Immunotherapy (SCIP) platform.
3
Funding Rounds
$400.0m
Money raised
Overview
Cell and Immunotherapy (SCIP) platform.
- Website:
- Business model: B2B
- Headquarters: Basel
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Cimeio Therapeutics has raised a total of $400m in funding over 3 rounds.
Key Insights:
- Cimeio Therapeutics Venture Round, December 2024: $300m
- Cimeio Therapeutics Series A round: $50m
- Cimeio Therapeutics April 2022 Series A Funding Round: $50m
Cimeio Therapeutics Venture Round, December 2024
$300m
Cimeio Therapeutics Series A round
$50m
Cimeio Therapeutics April 2022 Series A Funding Round
$50m
Industries
Cimeio Therapeutics is active in the following industries: